Opioid Recovery Taper Schedule Calculator
A visual taper reduction schedule — for use only with medical supervision.
⚠ Medical disclaimer — read before using
What tapering is and why it matters
Opioid tapering is the gradual reduction of opioid medication over time to minimize withdrawal symptoms while allowing the brain and body to readjust to lower doses. The goal is to reach either a lower therapeutic dose or complete discontinuation, depending on the clinical situation.
Abrupt opioid discontinuation causes withdrawal syndrome: severe pain, nausea, vomiting, anxiety, insomnia, and cardiovascular stress. In high-dose or long-duration users, abrupt cessation can be medically dangerous. A slow, supervised taper dramatically reduces these risks.
CDC guidelines on opioid dose reduction
The CDC's 2022 Clinical Practice Guideline for Prescribing Opioids recommends several evidence-based principles for tapering:
- Reduce dose by no more than 10% per week (or 10% per month for longer-term users), adjusted based on patient response.
- Taper more slowly at lower doses — the last 10–30% of a taper is often the most difficult.
- Never abruptly discontinue opioids in physically dependent patients.
- Consider buprenorphine (Suboxone) as a tapering aid — it is FDA-approved for opioid use disorder and significantly eases the tapering process.
- Address the underlying pain condition and mental health simultaneously.
What to expect during a taper
During a properly managed taper, mild withdrawal symptoms are normal and expected. These may include increased sensitivity to pain, sleep disruption, anxiety, and gastrointestinal discomfort. These symptoms should be manageable — severe symptoms are a signal to slow the taper rate, not push through. Your prescriber should provide clear guidance on what symptoms warrant contact and what management options are available.
Medications that help during opioid tapering
- Buprenorphine (Suboxone): FDA-approved for opioid use disorder. Can be initiated and managed in primary care settings. Dramatically reduces withdrawal and cravings.
- Clonidine: An alpha-2 agonist that reduces many autonomic withdrawal symptoms. Used off-label during opioid tapers.
- Naltrexone (Vivitrol): Used after detox is complete to block opioid effects and reduce cravings. Available in monthly injectable form.
- Non-opioid pain management: NSAIDs, gabapentin, and physical therapy may help manage underlying pain conditions during dose reduction.
Finding a prescriber who will support tapering
SAMHSA's Buprenorphine Practitioner Locator (findtreatment.gov) lists providers certified to prescribe buprenorphine for opioid use disorder. The PCSS (Provider Clinical Support System) offers free consultations for prescribers and can help connect patients with supportive providers. SAMHSA's National Helpline (1-800-662-4357) can also provide referrals to local treatment providers who specialize in opioid use disorder management.
The CDC's 2022 updated opioid guidelines explicitly state that rapid tapers and abrupt discontinuation are associated with serious patient harm including withdrawal, psychological distress, and in some cases return to illicit opioid use. The guidelines emphasize individualized, patient-centered tapering with clear informed consent.
Taper calculation methodology based on CDC 2022 Clinical Practice Guideline for Prescribing Opioids (Dowell et al., 2022, MMWR). Medical information reviewed against SAMHSA Treatment Improvement Protocol (TIP) 63 on medications for opioid use disorder.